Rare diseases
Investigational molecules
Locations
Study of Osimertinib and Chemotherapy for Patients with EGFR Mutation Positive Resectable Non-Small Cell Lung Cancer
AustriaStudy Comparing Selpercatinib with a Drug Combination for Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer
BelgiumStudy of Alectinib and Platinum-Based Chemotherapy for Patients with Resected Stage Ib to IIIa ALK-Positive Non-Small Cell Lung Cancer
AustriaStudy of Tisagenlecleucel for Adults with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma
AustriaStudy of Chemoradiotherapy With or Without Pembrolizumab for Patients With High-Risk, Locally Advanced Cervical Cancer
AustriaStudy of Pembrolizumab with Chemotherapy for Patients with Gastric or Gastroesophageal Junction Cancer
BelgiumStudy of Dazostinag and Pembrolizumab for Adults with Advanced or Metastatic Solid Tumors
AustriaStudy of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations
AustriaStudy Comparing Chemotherapy Alone to Chemotherapy with Nivolumab or Nivolumab and BMS-986205 for Patients with Muscle-Invasive Bladder Cancer
AustriaStudy of Durvalumab with Gemcitabine and Cisplatin for Patients with Advanced Biliary Tract Cancer
BulgariaStudy of TAR-200 and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Not Undergoing Radical Cystectomy
AustriaStudy on the Effectiveness of Retifanlimab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer
BulgariaTell us about your condition – we search every trial in Europe and connect you with the right site.
